Microbial cell wall and cytoplasmic membrane

The microbial cell wall and cytoplasmic membrane represent fundamental structural targets in antimicrobial therapy, providing both mechanical protection and physiological regulation for bacteria and fungi. The cell wall, composed primarily of peptidoglycan in bacteria or glucans and chitin in fungi, maintains cellular shape and prevents lysis due to internal osmotic pressure (StatPearls, 2023). Beneath this, the cytoplasmic membrane acts as a semi-permeable barrier essential for nutrient transport, energy generation, and signaling. Drugs like beta-lactams and glycopeptides target the synthesis of the cell wall, leading to cell death through osmotic rupture, while lipopeptides and polymyxins directly interact with the lipid components of the membrane to induce leakage of essential ions (NIH, 2022). Because these structures are often unique to microbes (such as the absence of peptidoglycan in human cells), they offer high therapeutic indices, although some membrane-targeting agents must be carefully managed due to potential toxicity to mammalian membranes. Understanding these targets is critical for addressing clinical infections and the rising challenge of antimicrobial resistance (PubMed, 2021).

Other names

Bacterial cell wallFungal cell wallMicrobial envelopeProkaryotic plasma membraneBacterial cytoplasmic membrane

Inhibition of peptidoglycan cross-linking, inhibition of cell wall synthesis (beta-glucan or chitin), disruption of membrane integrity, pore formation, and alteration of membrane potential leading to cytoplasmic leakage.